CROSSLINKED NUCLEIC ACID GUNA, METHOD FOR PRODUCING SAME, AND INTERMEDIATE COMPOUND
申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP3351548A1
公开(公告)日:2018-07-25
The present invention provides a method for producing guanidine crosslinked artificial nucleic acid (abbreviated hereinafter as GuNA), and an intermediate compound for the production thereof. Specifically, the present invention provides a method for producing a compound represented by general formula I: (in the formula, R1, R2, R3, R4, R5, R6, m and ring A are as defined in the specification) or a salt thereof wherein a reducing agent is reacted with a compound represented by general formula II: (in the formula, R1, R2, R3, R4, R5, R6, m, and ring A' are as defined in the specification).
本发明提供了一种生产胍交联人工核酸(以下缩写为 GuNA)的方法,以及用于生产该核酸的中间化合物。具体地说,本发明提供了一种生产通式 I 所代表的化合物:(式中,R1、R2、R3、R4、R5、R6、m 和环 A 如说明书中所定义)或其盐的方法,其中还原剂与通式 II 所代表的化合物反应:(式中,R1、R2、R3、R4、R5、R6、m 和环 A' 如说明书中所定义)。
ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF
申请人:RIKEN GENESIS CO., LTD.
公开号:US20230257413A1
公开(公告)日:2023-08-17
Disclosed is a compound represented by formula (1) or a salt thereof wherein: “Base” represents an aromatic heterocyclic group which may have a substituent, or an aromatic hydrocarbon ring group which may have a substituent; A
1
represents a single bond or an alkylene group; R
1
to R
5
represent an atom or a group disclosed in the specification.